BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 21600143)

  • 21. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hemophagocytic lymphohistiocytosis in a 6-week-old male infant.
    Jakovljević G; Kardum-Skelin I; Rogosić S; Culić S; Stepan J; Gagro A; Skarić I; Mikecin L; Bonevski A; Barisić I; Nakić M
    Coll Antropol; 2010 Jun; 34(2):631-4. PubMed ID: 20698142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis.
    Mukda E; Trachoo O; Pasomsub E; Tiyasirichokchai R; Iemwimangsa N; Sosothikul D; Chantratita W; Pakakasama S
    Int J Hematol; 2017 Aug; 106(2):282-290. PubMed ID: 28353193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis.
    Matsuda K; Nakazawa Y; Yanagisawa R; Honda T; Ishii E; Koike K
    Clin Chim Acta; 2011 Aug; 412(17-18):1554-8. PubMed ID: 21570959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
    Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
    Yang X; Miyawaki T; Kanegane H
    Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children.
    My LT; Lien le B; Hsieh WC; Imamura T; Anh TN; Anh PN; Hung NT; Tseng FC; Chi CY; Dao NT; Le DT; Thinh le Q; Tung TT; Imashuku S; Thuong TC; Su IJ
    Br J Haematol; 2010 Jan; 148(2):301-10. PubMed ID: 19863536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients.
    Bąbol-Pokora K; Wołowiec M; Popko K; Jaworowska A; Bryceson YT; Tesi B; Henter JI; Młynarski W; Badowska W; Balwierz W; Drabko K; Kałwak K; Maciejka-Kembłowska L; Pieczonka A; Sobol-Milejska G; Kołtan S; Malinowska I;
    Arch Immunol Ther Exp (Warsz); 2021 Oct; 69(1):31. PubMed ID: 34677667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a novel splicing mutation in UNC13D gene through amplicon sequencing: a case report on HLH.
    Liu D; Hu X; Jiang X; Gao B; Wan C; Chen C
    BMC Med Genet; 2017 Nov; 18(1):135. PubMed ID: 29157204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An analysis of etiological and genetic factors of a patient with familial hemophagocytic lymphohistiocytosis].
    Liu HX; Tong CR; Wang H; Zhu J; Wang F; Cai P; Teng W; Yang JF; Zhang YL; Lu DP
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):132-5. PubMed ID: 21418834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2.
    Seo JY; Lee KO; Yoo KH; Sung KW; Koo HH; Kim SH; Kang HJ; Park KD; Shin HY; Baek HJ; Kook H; Lyu CJ; Song JS; Lee MJ; Kim JY; Lim YT; Koh KN; Im HJ; Seo JJ; Kim HJ;
    Clin Genet; 2016 Feb; 89(2):222-7. PubMed ID: 26451869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.
    Zhang K; Jordan MB; Marsh RA; Johnson JA; Kissell D; Meller J; Villanueva J; Risma KA; Wei Q; Klein PS; Filipovich AH
    Blood; 2011 Nov; 118(22):5794-8. PubMed ID: 21881043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
    Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
    Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity.
    Viñas-Giménez L; Donadeu L; Alsina L; Rincón R; de la Campa EÁ; Esteve-Sole A; Català A; Colobran R; de la Cruz X; Sayós J; Martínez-Gallo M
    Int J Hematol; 2020 Mar; 111(3):440-450. PubMed ID: 31865540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expanding spectrum of hemophagocytic lymphohistiocytosis.
    Filipovich AH
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):512-6. PubMed ID: 21971331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.